{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:19:03Z","timestamp":1773796743757,"version":"3.50.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01174","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T05:41:45Z","timestamp":1595396505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials"],"prefix":"10.3389","volume":"10","author":[{"given":"Marco","family":"Marcello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Denham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Steigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois C.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Jameson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Dearnaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Sydes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence : a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.clon.2011.03.001","article-title":"The impact of clinical factors on the development of late radiation toxicity : results from the medical research council RT01 trial (ISRCTN47772397)","volume":"23","author":"Barnett","year":"2011","journal-title":"Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"E240","DOI":"10.1016\/j.ijrobp.2015.07.1153","article-title":"Multivariable models predicting specific patient-reported acute urinary symptoms after radiation therapy for prostate cancer: results of a cohort study","volume":"93","author":"Rancati","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.radonc.2015.06.011","article-title":"Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial","volume":"116","author":"Yahya","year":"2015","journal-title":"Radiother Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijrobp.2004.01.024","article-title":"Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate","volume":"59","author":"Luxton","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.ijrobp.2009.07.242","article-title":"Image-Guided Radiation Therapy (IGRT) in prostate cancer: preliminary results in prostate registration and acute toxicity of a randomized study","volume":"75","author":"De Crevoisier","year":"2009","journal-title":"Radiat Oncol Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2019.01.088","article-title":"Voxel-based analysis for identification of urethrovesical subregions predicting urinary toxicity after prostate cancer radiation therapy","volume":"104","author":"Mylona","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.ejmp.2016.08.013","article-title":"Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer","volume":"32","author":"Improta","year":"2016","journal-title":"Phys Medica"},{"key":"B10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijrobp.2016.10.024","article-title":"Modeling urinary dysfunction after external beam radiation therapy of the prostate using bladder dose-surface maps: evidence of spatially variable response of the bladder surface","volume":"97","author":"Yahya","year":"2018","journal-title":"Radiat Oncol Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.radonc.2016.02.025","article-title":"First application of a pixel-wise analysis on bladder dose \u2013 surface maps in prostate cancer radiotherapy","volume":"119","author":"Palorini","year":"2016","journal-title":"Radiother Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.clon.2018.05.001","article-title":"An investigation of dosimetric correlates of acute toxicity in prostate stereotactic body radiotherapy: dose to urinary trigone is associated with acute urinary toxicity","volume":"30","author":"Henderson","year":"2018","journal-title":"Clin Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ctro.2017.09.005","article-title":"Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: a 10-year follow-up study of genitourinary toxicity in clinical practice","volume":"6","author":"Inokuchi","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"B15","unstructured":"Spatial nonparametric mixed-effects model with spatial-varying coefficients for analysis of populations\n            OspinaJD\n            AcostaO\n            Dr\u00e9anG\n            CazoulatG\n            SimonA\n            CorreaJCC\n          \n            SuzukiK\n            WangF\n            ShenD\n            YanP\n          Vol. 7009. Berlin; HeidelbergSpringerMachine Learning in Medical Imaging. MLMI 2011. Lecture Notes in Computer Science2011"},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1748-717X-8-293","article-title":"Multiple comparisons permutation test for image based data mining in radiotherapy","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S1470-2045(14)70328-6","article-title":"Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial","volume":"15","author":"Denham","year":"2014","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.radonc.2015.05.016","article-title":"Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial","volume":"115","author":"Denham","year":"2015","journal-title":"Radiother Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.radonc.2007.11.013","article-title":"Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system","volume":"86","author":"Ebert","year":"2008","journal-title":"Radiother Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","article-title":"Escalated-dose versus control-dose conformal radiotherapy for prostate cancer : long-term results from the MRC RT01 randomised controlled trial","volume":"15","author":"Dearnaley","year":"2014","journal-title":"Lancet Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial","volume":"13","author":"Dearnaley","year":"2012","journal-title":"Lancet Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.radonc.2004.04.007","article-title":"Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer","volume":"72","author":"Sydes","year":"2004","journal-title":"Radiother Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.clon.2019.05.009","article-title":"Radiotherapy quality assurance for the CHHiP trial: conventional versus hypofractionated high-dose intensity-modulated radiotherapy in prostate cancer","volume":"31","author":"Naismith","year":"2019","journal-title":"Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/mp.13494","article-title":"Similarity clustering based atlas selection for pelvic CT image segmentation","volume":"46","author":"Kennedy","year":"2019","journal-title":"Med Phys"},{"key":"B27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2012.10.006","article-title":"Bioeffect modeling and equieffective dose concepts in radiation oncology-Terminology, quantities and units","volume":"105","author":"Bentzen","year":"2012","journal-title":"Radiother Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0360-3016(95)90159-0","article-title":"LENT-SOMA scales for all anatomic sites","volume":"31","author":"Pavi","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage."},{"key":"B30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1214\/12-AOS1058","article-title":"On the definition of a confounder","volume":"41","author":"VanderWeele","year":"2013","journal-title":"Ann Stat"},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.radonc.2017.10.021","article-title":"Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: results from the TROG 03.04 RADAR trial","volume":"126","author":"Marcello","year":"2018","journal-title":"Radiother Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2510-17-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshiranit","year":"1996","journal-title":"J R Stat Soc Ser B."},{"key":"B33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00345-013-1146-8","article-title":"Nomograms to predict late urinary toxicity after prostate cancer radiotherapy","volume":"32","author":"Mathieu","year":"2014","journal-title":"World J Urol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4103\/1008-682X.146972","article-title":"Re-epithelialization resulted from prostate basal cells in canine prostatic urethra may represent the ideal healing method after two-micron laser resection of the prostate","volume":"17","author":"Cao","year":"2015","journal-title":"Asian J Androl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.eururo.2016.04.022","article-title":"Adipose-derived stem cells counteract urethral stricture formation in rats","volume":"70","author":"Castiglione","year":"2016","journal-title":"Eur Urol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.radonc.2014.04.005","article-title":"Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions","volume":"112","author":"De Langhe","year":"2014","journal-title":"Radiother Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.ijrobp.2018.08.015","article-title":"A systematic post-QUANTEC review of tolerance doses for late toxicity after prostate cancer radiation therapy","volume":"102","author":"Olsson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.radonc.2015.10.003","article-title":"Urinary symptoms following external beam radiotherapy of the prostate :dose \u2013 symptom correlates with multiple-event and event-count models","volume":"117","author":"Yahya","year":"2015","journal-title":"Radiother Oncol"},{"key":"B39","unstructured":"Macroscopic haematuria: a urological approach123\n            YeohM\n            LaiNK\n            AndersonD\n            AppaduraiV\n          23529521Aust Fam Physician.422013"},{"key":"B40","first-page":"S2","article-title":"The prevalence of urinary incontinence","volume":"3","author":"Nitti","year":"2001","journal-title":"Rev Urol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5213\/inj.2012.16.3.102","article-title":"Clinical and functional anatomy of the urethral sphincter","volume":"16","author":"Jung","year":"2012","journal-title":"Int Neurourol J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/ca.22388","article-title":"Continence and micturition: an anatomical basis","volume":"27","author":"Shah","year":"2014","journal-title":"Clin Anat."},{"key":"B43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ijrobp.2008.02.073","article-title":"Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer","volume":"72","author":"Al-Mamgani","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuroimage.2008.03.061","article-title":"Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference","volume":"44","author":"Smith","year":"2009","journal-title":"Neuroimage"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ijrobp.2015.04.024","article-title":"Multileaf collimator tracking improves dose delivery for prostate cancer radiation therapy : results of the first clinical trial","volume":"92","author":"Colvill","year":"2015","journal-title":"Radiat Oncol Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.radonc.2017.04.008","article-title":"Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy","volume":"123","author":"Shelley","year":"2017","journal-title":"Radiother Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0179845","DOI":"10.1371\/journal.pone.0179845","article-title":"Nomogram to predict rectal toxicity following prostate cancer radiotherapy","volume":"12","author":"Delobel","year":"2017","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3978\/j.issn.2218-676X.2015.04.06","article-title":"Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance","volume":"4","author":"Emami","year":"2015","journal-title":"Transl Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fonc.2019.00130","article-title":"PACE: a probabilistic atlas for normal tissue complication estimation in radiation oncology","volume":"9","author":"Palma","year":"2019","journal-title":"Front Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.radonc.2006.07.037","article-title":"Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)","volume":"80","author":"Mangar","year":"2006","journal-title":"Radiother Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ctro.2019.12.006","article-title":"Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial","volume":"21","author":"Murray","year":"2020","journal-title":"Clin Transl Radiat Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1464-410X.2008.07505.x","article-title":"Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer","volume":"102","author":"DiBlasio","year":"2008","journal-title":"BJU Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1743-6109.2010.02164.x","article-title":"Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215","volume":"8","author":"Bruner","year":"2011","journal-title":"J Sex Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.radonc.2012.09.018","article-title":"Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer","volume":"105","author":"Denham","year":"2012","journal-title":"Radiother Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T05:41:51Z","timestamp":1595396511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":55,"alternative-id":["10.3389\/fonc.2020.01174"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01174","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"article-number":"1174"}}